Yong Chan Ahn
Overview
Explore the profile of Yong Chan Ahn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
231
Citations
3518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma S, Ahn Y, Lim D, Lee J, Seol H, Lee W, et al.
J Neurooncol
. 2025 Mar;
PMID: 40069531
Purpose: To survey the real-world effectiveness and cost of optic nerve sheath meningioma (ONSM) treating with Gamma Knife Radiosurgery (GKRS), and compare with the external beam radiation therapy (EBRT). Methods:...
2.
Lee T, Seo S, Shin H, Son H, Kim K, Ahn Y, et al.
Radiother Oncol
. 2025 Mar;
206:110830.
PMID: 40049516
Purpose: This study aimed to estimate the 30-day mortality (30D_M) and compare models for 30D_M prediction in patients undergoing palliative radiation therapy (RT). Materials And Methods: Data from 3,756 patients...
3.
Choi J, Choi J, Woo S, Moon J, Lim C, Park S, et al.
J Pers Med
. 2025 Feb;
15(2).
PMID: 39997352
In the original publication [...].
4.
Park S, Ahn Y, Oh D, Yang K, Ju S, Kim J, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941919
: We aimed to compare the salivary gland volume changes following intensity-modulated radiation therapy (IMRT) alone versus IMRT/intensity-modulated proton therapy (IMPT) combination in oropharyngeal cancer (OPC). : We retrospectively reviewed...
5.
Kim Y, Choi N, Kim E, Chung M, Son Y, Oh D, et al.
Oncology
. 2024 Dec;
:1-11.
PMID: 39715602
Introduction: This study aimed to report the efficacy and safety of adjuvant sequential chemotherapy after definitive treatment of salivary duct carcinoma (SDC) compared with the standard treatment alone (surgery with...
6.
Lee C, Choo J, Ahn Y, Kim J, Rha S, Rim C
Cancer Res Treat
. 2024 Dec;
57(1):11-18.
PMID: 39638248
During the celebration of the 50th anniversary of the founding of the Korean Cancer Association, articles published in Cancer Research and Treatment from 2004 to 2023 were assessed based on...
7.
Ko M, Yang K, Ahn Y, Ju S, Oh D, Kim Y, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39410022
Background: Proton therapy requires caution when treating patients with targets near neural structures. Intuitive and quantitative guidelines are needed to support decision-making concerning the treatment modality. This study compared dosimetric...
8.
Kang H, Do W, Ahn Y, Chie E, Rim C
Eur J Cancer
. 2024 Oct;
212:115043.
PMID: 39357277
Introduction: Oligometastasis (OM) exhibits wide range of prognosis, which necessitates appropriate classification for optimal therapeutic decision-making. Complementing the ESTRO-EORTC classification which lacked prognostic differentiation and was rather complex, we propose...
9.
Park S, Kim J, Ahn Y, Koom W, Byun H, Kim Y, et al.
Cancers (Basel)
. 2024 Jul;
16(14).
PMID: 39061193
Background: One important determinant in choosing a treatment modality is spinal instability. Clear management guidelines are suggested for stable and unstable spinal metastatic lesions, but lesions in the intermediate instability...
10.
Cho W, Noh J, Oh D, Ahn Y, Sun J, Kim H, et al.
Cancer Res Treat
. 2024 Jul;
57(1):165-173.
PMID: 39054622
Purpose: There is few evidence regarding the optimal salvage treatment options for loco-reginal recurrence of esophageal cancer. This study aimed to evaluate the clinical outcomes of salvage radiotherapy (RT) in...